首页> 外文期刊>The Biochemical Journal >THE PRIMARY ELASTASE INHIBITOR (ELASTASIN) AND TRYPSIN INHIBITOR (CONTRAPSIN) IN THE GOAT ARE SERPINS RELATED TO HUMAN ALPHA(1)-ANTI-CHYMOTRYPSIN
【24h】

THE PRIMARY ELASTASE INHIBITOR (ELASTASIN) AND TRYPSIN INHIBITOR (CONTRAPSIN) IN THE GOAT ARE SERPINS RELATED TO HUMAN ALPHA(1)-ANTI-CHYMOTRYPSIN

机译:山羊中的主要弹性蛋白酶抑制剂(弹性蛋白酶)和胰蛋白酶抑制剂(避孕药)与人α(1)-抗胰蛋白酶有关。

获取原文
获取原文并翻译 | 示例
           

摘要

Two primary serine proteinase inhibitors in goat plasma have been isolated and characterized. The N-terminal sequence analysis of the purified proteins revealed that they are closely related to each other and are highly homologous to human alpha(1)-anti-chymotrypsin rather than alpha(1)-proteinase inhibitor. However, despite structural similarities the inhibitory specificity of the goat inhibitors differed from each other and from that of anti-chymotrypsin. In contrast with human anti-chymotrypsin, one of the goat inhibitors was shown to be a strong and specific inhibitor of trypsin (k(ass.) = 1.9 x 10(6) M(-1).s(-1)), whereas the other was an efficient inhibitor of neutrophil elastase (k(ass.) = 1.5 x 10(6) M(-1).s(-1)). Differences in the inhibitory specificity of each protein could readily be attributed to the amino acid sequence within the reactive site region. The trypsin inhibitor with an assumed arginine residue at the P-1 position of the reactive-site peptide bond is referred to as 'contrapsin', and indicates that the occurrence of contrapsins is not restricted to rodents. In contrast, the inhibitory specificity, resistance to oxidative and proteolytic inactivation and the presence of a P-1 leucine residue in the elastase inhibitor is unique among inhibitory serpins that have been characterized to date. Because this serpin is apparently the major elastase inhibitor in goat plasma, it is likely to be involved in the control of goat neutrophil elastase. Therefore, we suggest the name 'elastasin', and extend it to any other anti-chymotrypsin related serpins possessing neutrophil-elastase-inhibitory activity.
机译:山羊血浆中的两种主要丝氨酸蛋白酶抑制剂已被分离和鉴定。纯化蛋白的N端序列分析表明,它们彼此密切相关,并且与人alpha(1)-抗胰凝乳蛋白酶而不是alpha(1)-蛋白酶抑制剂高度同源。但是,尽管在结构上相似,山羊抑制剂的抑制特异性和抗胰凝乳蛋白酶的抑制特异性却有所不同。与人抗胰凝乳蛋白酶相反,一种山羊抑制剂被证明是胰蛋白酶的强而特异性抑制剂(k(ass。)= 1.9 x 10(6)M(-1).s(-1)),而另一种是中性粒细胞弹性蛋白酶的有效抑制剂(k(ass。)= 1.5 x 10(6)M(-1).s(-1))。每种蛋白质抑制特异性的差异很容易归因于反应位点区域内的氨基酸序列。在反应位点肽键的P-1位置具有精氨酸残基的胰蛋白酶抑制剂被称为“伴生蛋白”,表明伴生蛋白的存在并不局限于啮齿动物。相反,在迄今已表征的抑制性丝氨酸蛋白酶抑制剂中,抑制特异性,对氧化和蛋白水解失活的抗性以及在弹性蛋白酶抑制剂中P-1亮氨酸残基的存在是独特的。因为这种丝氨酸蛋白酶抑制剂显然是山羊血浆中的主要弹性蛋白酶抑制剂,所以它很可能参与了山羊嗜中性粒细胞弹性蛋白酶的控制。因此,我们建议使用“弹性蛋白”的名称,并将其扩展到具有中性粒细胞弹性蛋白酶抑制活性的任何其他抗胰凝乳蛋白酶相关丝氨酸蛋白酶抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号